Evidence map›Paper›PMID 40213436›Full record

ArticleFrontiers in public health2025

Use of a pathogen X tabletop exercise to assess the operational response preparedness of an emerging infectious diseases research network.

Rachael Lee, Jennifer Hemingway-Foday, Nefer Batsuli, L Danielle Wagner, Aaron Macoubray, Robert F Garry, Christine K Johnson, Kathryn A Hanley, Nikos Vasilakis, Souleymane Mboup and 14 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Rachael Lee *RTI International, Research Triangle Park, NC, United States.
Jennifer Hemingway-Foday *RTI International, Research Triangle Park, NC, United States.
Nefer BatsuliRTI International, Research Triangle Park, NC, United States.
L Danielle WagnerRTI International, Research Triangle Park, NC, United States.
Aaron MacoubrayRTI International, Research Triangle Park, NC, United States.
Robert F GarryDepartment of Microbiology and Immunology, Tulane School of Medicine, New Orleans, LA, United States.
Christine K JohnsonEpiCenter for Disease Dynamics, One Health Institute, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.
Kathryn A HanleyDepartment of Biology, New Mexico State University, Las Cruces, NM, United States.
Nikos VasilakisDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, United States.
Souleymane MboupInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formations, Dakar, Senegal.
Hongying LiEcoHealth Alliance, New York, NY, United States.
Cecilia A SánchezEcoHealth Alliance, New York, NY, United States.
Peter M RabinowitzDepartment of Global Health, University of Washington School of Public Health, Seattle, WA, United States.
Robert F BreimanRollins School of Public Health, Emory University, Atlanta, GA, United States.
Nathan VandergriftRTI International, Research Triangle Park, NC, United States.
Eric J EarleyRTI International, Research Triangle Park, NC, United States.
Hilary Bouton-VervilleDuke Department of Pediatrics, Duke University School of Medicine, Durham, NC, United States.
E Candice BeaubienNational Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States.
E Megan DavidsonDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, United States.
Gretchen Van VlietRTI International, Research Triangle Park, NC, United States.
Sara WoodsonNational Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States.
M Anthony MoodyDuke Department of Pediatrics, Duke University School of Medicine, Durham, NC, United States.
Gregory D SempowskiRTI International, Research Triangle Park, NC, United States.
Richard ReithingerRTI International, Research Triangle Park, NC, United States.

Funding

Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC)U01AI151378 · NIAID · RESEARCH TRIANGLE INSTITUTE · PI Gregory D Sempowski · 2020 to 2026
$14.7M
University of Washington Arboviral Research Network (UWARN)U01AI151698 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale, PETER MACGARR RABINOWITZ · 2020 to 2026
$13.3M
West African Emerging Infectious Disease Research Center (WA-EIDRC)U01AI151812 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ANDERSEN, KRISTIAN GRAUGAARD, GARRY, ROBERT F · 2020 to 2024
$13.2M
Emerging Infectious Diseases Research Center - East and Central AfricaU01AI151799 · NIAID · WASHINGTON STATE UNIVERSITY · PI M KARIUKI NJENGA · 2020 to 2026
$10.4M
West African Center for Emerging Infectious DiseasesU01AI151801 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Robert W Cross, Scott C Weaver · 2020 to 2026
$10.1M
Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI151807 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Kathryn Alyce Hanley, MAURICIO Lacerda NOGUEIRA · 2020 to 2026
$9.8M
NIAID NIH HHS U01 AI151378NIAID NIH HHS U01 AI151698NIAID NIH HHS U01 AI151799NIAID NIH HHS U01 AI151801NIAID NIH HHS U01 AI151807NIAID NIH HHS U01 AI151812
6 · The paper itself

Abstract

In mid-2020, the Centers for Research in Emerging Infectious Diseases (CREID) Network was established to address critical gaps in research expertise and capacity in emerging and re-emerging infectious diseases (EIDs). As the Network was established during the COVID-19 pandemic, most of the Network's research centers initially focused on SARS-CoV-2 research. By the end of 2021, the Network leadership realized that it had a blind spot with regards to research centers and their sites' overall capacities and stakeholder connections. To foster more meaningful and deeper levels of coordination and collaboration across research centers, as well as stress-test its capacity and readiness for rapid research during an EID outbreak. CREID conducted a tabletop exercise (TTX) during its Annual Partners Meeting in August 2022. Through the 2-day TTX, participants provided insight into their institutions' resources, stakeholder relationships, and research engagement before and after an EID outbreak; additionally, technical and operational challenges and solutions with regards to a successful outbreak research response were discussed. TTX participants' feedback was used to improve the Network's operational research response framework and processes. Given the limited existing resources on TTX for infectious disease outbreaks, the materials developed for the TTX and reported here can serve as a reference for determining and preparing for any research institution's role in pandemic preparedness and response research efforts.

Indexed as

Biomedical ResearchCommunicable Diseases, EmergingCOVID-19Disease OutbreaksHumansPandemicsSARS-CoV-2emerging infectious diseaseglobal healthpreparedness and responsepublic healthtabletop exercise

Identifiers

PMID40213436
PMCPMC11983644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.